Vertex gets EC nod for Kalydeco to treat children and adolescents with cystic fibrosis
Vertex Pharmaceuticals Incorporated announced that the European Commission has granted approval of the label extension for KALYDECO (ivacaftor) to include the treatment of children and…
Read More...
Read More...